The new London store offers advancements in sustainable design, community events and resources, and a team of more than 200 ready to provide excellent service for customers LONDON–(BUSINESS WIRE)–Apple® today previewed Apple Brompton Road, its newest store in London, located in the city’s bustling Knightsbridge neighborhood. A stone’s throw from Hyde Park, Apple Brompton Road … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Taste Masking and Taste Assessment Services and Technologies Market, Distribution by Type of Formulation, Type of Techniques, Scale of Operation and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035” report has been added to ResearchAndMarkets.com’s offering. ‘Taste Masking and Taste Assessment Services and Technologies Market, 2022-2035 report features an extensive study of … [Read more…]
SINGAPORE–(BUSINESS WIRE)–#HD204—Prestige Biopharma Limited (KRX: 950210, hereafter referred to as “Prestige”) and Intas Pharmaceuticals Limited (hereafter referred to as “Intas”) today announced that the two companies have entered into a binding agreement for the exclusive partnership and supply for the commercialization of Prestige Biopharma’s bevacizumab biosimilar, in the US, Europe, Canada, MENA, Brazil, Mexico, South … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Acquired von Willebrand Disease (AvWD) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030” report has been added to ResearchAndMarkets.com’s offering. The acquired von willebrand disease treatment market is anticipated to grow, at a CAGR of 5.86% during the forecast period of … [Read more…]
– Companies plan to discuss results with regulatory authorities – BOTHELL, Wash. & TOKYO–(BUSINESS WIRE)–Seagen Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced positive topline results from the phase 1b/2 EV-103 clinical trial (also known as KEYNOTE-869) Cohort K evaluating PADCEV® (enfortumab vedotin-ejfv) in combination with Merck’s … [Read more…]
PALO ALTO, Calif.–(BUSINESS WIRE)–ReCor Medical, Inc. (“ReCor”) and Otsuka Medical Devices Co., Ltd., a fully owned subsidiary of Otsuka Holdings Co., Ltd., today announced that the RADIANCE II US FDA IDE pivotal trial evaluating the Paradise™ Ultrasound Renal Denervation (uRDN) System as a treatment for hypertension met its primary efficacy endpoint, demonstrating a statistically significant … [Read more…]
SHENZHEN, China–(BUSINESS WIRE)–SMOORE, the world’s largest vape manufacturer, today announced that is has opened China’s first non-clinical full-scale testing laboratory for Premarket Tobacco Product Applications (PMTA). A PMTA is an application that must be reviewed and approved by the Food and Drug Administration (FDA) before a new nicotine product can be legally marketed in the … [Read more…]
Strategic investment to support the foundation of Solena Materials, a spin-out from Imperial College London, accelerating the development of synthetic fibers for high-performance, intrinsically sustainable clothing MUNICH–(BUSINESS WIRE)–Insempra, a biology-powered company enabling businesses to make superior products in partnership with nature, today announces a strategic investment in Solena Materials Ltd (‘Solena’), a synthetic biology company. … [Read more…]
LONDON–(BUSINESS WIRE)–Smiths Detection, a global leader in threat detection and security screening technologies, has today been announced as a sponsor and supplier of X-ray screening and detection equipment for the Birmingham 2022 Commonwealth Games, helping to create a secure environment for all attendees. The Games will attract over one million visitors between 28 July and … [Read more…]
TEL AVIV, Israel–(BUSINESS WIRE)–Genetika+, a company developing personalized medicine solutions to optimize treatment for psychiatric and neurological diseases, announced today an award of up to €17.5 million of grant funding combined with equity investment to bring NeuroKaire to market. This represents the maximum possible grant from the European Commission and will be used for the … [Read more…]
